🇺🇸 FDA
Pipeline program

Group A (the standard 2HRZE/4HR regimen)

K18-103

Approved small_molecule completed

Quick answer

Group A (the standard 2HRZE/4HR regimen) for Pulmonary Tuberculosis TB in Sputum: (+) Microscopy is a Approved program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials